These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
739 related articles for article (PubMed ID: 16308159)
1. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium. Afify AM; Craig S; Paulino AF; Stern R Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of CD44s and CD44v6 in endometriosis and adenomyosis : comparison with normal, hyperplastic, and malignant endometrium. Lin Z; Cho S; Jeong H; Kim H; Kim I J Korean Med Sci; 2001 Jun; 16(3):317-22. PubMed ID: 11410693 [TBL] [Abstract][Full Text] [Related]
3. Temporal variation in the distribution of hyaluronic acid, CD44s, and CD44v6 in the human endometrium across the menstrual cycle. Afify AM; Craig S; Paulino AF Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):328-33. PubMed ID: 16932025 [TBL] [Abstract][Full Text] [Related]
4. Expression of CD44s, CD44v6, and hyaluronan across the spectrum of normal-hyperplasia-carcinoma in breast. Afify A; McNiel MA; Braggin J; Bailey H; Paulino AF Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):121-7. PubMed ID: 18227732 [TBL] [Abstract][Full Text] [Related]
5. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma. Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of transforming growth factor beta isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action. Gold LI; Saxena B; Mittal KR; Marmor M; Goswami S; Nactigal L; Korc M; Demopoulos RI Cancer Res; 1994 May; 54(9):2347-58. PubMed ID: 8162580 [TBL] [Abstract][Full Text] [Related]
7. Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization. Afify AM; Stern R; Michael CW Diagn Cytopathol; 2005 Mar; 32(3):145-50. PubMed ID: 15690337 [TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone-related peptide (PTH-rp) in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis. Mylonas I; Makovitzky J; Shabani N; Richter DU; Jeschke U; Briese V; Friese K Anticancer Res; 2005; 25(3A):1633-8. PubMed ID: 16033073 [TBL] [Abstract][Full Text] [Related]
9. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion. Afify A; Purnell P; Nguyen L Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378 [TBL] [Abstract][Full Text] [Related]
10. Oestrogen and progesterone receptor immunocytochemistry in human hyperplastic and neoplastic endometrium. Snijders MP; de Goeij AF; Koudstaal J; Thunnissen EB; de Haan J; Bosman FT J Pathol; 1992 Feb; 166(2):171-7. PubMed ID: 1560318 [TBL] [Abstract][Full Text] [Related]
11. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium. Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221 [TBL] [Abstract][Full Text] [Related]
12. Inhibin (10.7 kD prostatic peptide) in normal, hyperplastic, and malignant human endometria: an immunohistochemical study. Teni TR; Sampat MB; Sheth NA J Pathol; 1992 Sep; 168(1):35-40. PubMed ID: 1453268 [TBL] [Abstract][Full Text] [Related]
13. GLUT-1 is preferentially expressed in atypical endometrial hyperplasia and endometrial adenocarcinoma. Ashton-Sager A; Paulino AF; Afify AM Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):187-92. PubMed ID: 16785788 [TBL] [Abstract][Full Text] [Related]
14. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry. Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685 [TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic significance of urokinase and plasminogen activator inhibitor type-1 in endometrial hyperplasia and cancer. Taponeco F; Curcio C; Giuntini A; Nardini V; Fornaciari G; Artini PG; D'Ambrogio G; Genazzani AR J Exp Clin Cancer Res; 2001 Jun; 20(2):239-46. PubMed ID: 11484981 [TBL] [Abstract][Full Text] [Related]
16. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer. Woo MM; Alkushi A; Verhage HG; Magliocco AM; Leung PC; Gilks CB; Auersperg N Clin Cancer Res; 2004 Dec; 10(23):7958-64. PubMed ID: 15585630 [TBL] [Abstract][Full Text] [Related]
17. Cathepsin D expression in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis. Mylonas I; Makovitzky J; Richter DU; Jeschke U; Briese V; Friese K Acta Histochem; 2003; 105(3):245-52. PubMed ID: 13677618 [TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemical study of the expression of receptors to steroid hormones in endometrial hyperplastic processes]. Lysenko ON; Ashkhab MKh; Strizhova NV; Babichenko II Arkh Patol; 2004; 66(2):7-10. PubMed ID: 15154374 [TBL] [Abstract][Full Text] [Related]
19. Production of activin A in hyperplasia and adenocarcinoma of the human endometrium. Otani T; Minami S; Yamoto M; Umesaki N Gynecol Oncol; 2001 Oct; 83(1):31-8. PubMed ID: 11585411 [TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in normal, hyperplastic, and neoplastic endometrium. Morgan KG; Wilkinson N; Buckley CH J Pathol; 1996 Jul; 179(3):317-20. PubMed ID: 8774489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]